• Latest Posts

German Alzheimer’s Drug Backed with €43M After Biogen’s Surprise Turnaround

German Drug to Stop the Progression of Alzheimer’s Enters Phase IIb

German Scientists Publish New Mechanism of Action Against Alzheimer’s

German Biotech Unveils Positive Phase II Results for Alzheimer’s

A Dutch University Hospital has Halted Amyloid Beta Drug Studies


What Does ‘Anti-Aging Treatment’ Mean in Biotech?

Following Eli Lilly’s Failure, what’s Next in Alzheimer’s Treatments?

Leading German Biotech recruits New talent for Fight against Alzheimer’s

To IPO or not to IPO when you are a Biotech company? #BIO-Europe 2015

2014, the Biggest Year Ever for European Biotech IPOs